Mok Ngai-Shing, Lo Ying-Keung, Tsui Ping-Tim, Lam Ching-Wan
Cardiology Team, Department of Medicine & Geriatrics, Princess Margaret Hospital, Hong Kong, China.
J Cardiovasc Electrophysiol. 2005 Dec;16(12):1375-7. doi: 10.1111/j.1540-8167.2005.00299.x.
Ketoconazole is not known to be proarrhythmic without concomitant use of QT interval-prolonging drugs. We report a woman with coronary artery disease who developed a markedly prolonged QT interval and torsades de pointes (TdP) after taking ketoconazole for treatment of fungal infection. Her QT interval returned to normal upon withdrawal of ketoconazole. Genetic study did not find any mutation in her genes that encode cardiac IKr channel proteins. We postulate that by virtue of its direct blocking action on IKr, ketoconazole alone may prolong QT interval and induce TdP. This calls for attention when ketoconazole is administered to patients with risk factors for acquired long QT syndrome.
已知酮康唑在未同时使用延长QT间期药物的情况下不会引发心律失常。我们报告了一名患有冠状动脉疾病的女性,她在服用酮康唑治疗真菌感染后出现了明显延长的QT间期和尖端扭转型室速(TdP)。停用酮康唑后,她的QT间期恢复正常。基因研究未发现她编码心脏IKr通道蛋白的基因有任何突变。我们推测,酮康唑可能仅凭其对IKr的直接阻断作用就可延长QT间期并诱发TdP。在给有获得性长QT综合征危险因素的患者使用酮康唑时,这一点需要引起注意。